Abstract
BackgroundClinical and epidemiological evidence implicates elevated lipoprotein (a) [Lp(a)] level as a risk factor for cardiovascular disease (CVD).1 Lp(a) is also implicated as a causal agent in the atherothrombotic process.1...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
